Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
AOD-9604 has been tested in over 900 human participants across six randomized, double-blind, placebo-controlled trials
(2001) investigated AOD9604 in obese Zucker rats and observed that chronic administration was associated with reduced body weight gain without changes in IGF-1 levels or glucose tolerance, distinguishing its activity profile from that of full-length growth hormone [1]
Most of the product licences, or marketing authorities as they are called in the UK, for hydroxocobalamin date from the 1990s when the requirement for evidence was different than it is now
Your body is responding to the new signaling, but fat mobilization takes time to produce measurable changes
US$ 25.37
US$ 24.57
US$ 28.90
